AHA 2012.

Day 3

SWISS AMI: Stem cells infusion after primary angioplasty

The trial enrolled 200 patients post AMI treated with successful PCI, with LVEF ≤45% randomized to placebo,...

solaci - 24 June, 2015

Day 3

PILOT trial: Pilot study of two levels of hypothermia in comatose survivors after out-of-hospital cardiorespiratory arrest.

Hypothermia is neuroprotective, because it reduces brain oxygen consumption in 6%, suppresses chemical reactions associated to reperfusion,...

solaci - 24 June, 2015

Day 3

ALCADIA: An intra-myocardial injection of autologous cardiac derived stem cells improves ventricular function in patients with ischemic cardiomyopathy.

This is an open trial that included 7 patients with ischemic cardiomyopathy and reduced the ejection fraction...

solaci - 24 June, 2015

Day 3

SCIPIO trial: Intracoronary infusion of autologous cardiac stem cells improve ventricular function.

This is the first trial that used autologous cardiac stem cells for the treatment of ischemic cardiomyopathy....

solaci - 24 June, 2015

Day 3

POSEIDON: Transendocardial infusion of autologous vs. allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy.

Safety and efficacy of autologous vs. allogeneic mesenchymal stem cells had not yet been compared. This trial...

solaci - 24 June, 2015

Day 3

TIME: Use and duration of bone marrow derived stem cells infusion for the treatment of post infarction ventricular dysfunction.

This study randomized 120 patients with acute myocardial infarction after successful primary angioplasty with a residual ejection...

solaci - 24 June, 2015

Day 2

PHS II Trial: Use of multivitamins in the prevention of cardiovascular disease in men.

Observational studies have shown contradicting results on the use of multivitamins. PHS II is the only randomized...

solaci - 24 June, 2015

Day 2

GAUSS trial: Antibodies for the treatment of hypercholesterolemia in patients with statin intolerance.

Statins are the most effective treatment to reduce LDL levels and cardiovascular risk, 10-20% of patients are...

solaci - 24 June, 2015

SWISS AMI: Stem cells infusion after primary angioplasty

PILOT trial: Pilot study of two levels of hypothermia in comatose survivors after out-of-hospital cardiorespiratory arrest.

ALCADIA: An intra-myocardial injection of autologous cardiac derived stem cells improves ventricular function in patients with ischemic cardiomyopathy.

SCIPIO trial: Intracoronary infusion of autologous cardiac stem cells improve ventricular function.

POSEIDON: Transendocardial infusion of autologous vs. allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy.

TIME: Use and duration of bone marrow derived stem cells infusion for the treatment of post infarction ventricular dysfunction.

PHS II Trial: Use of multivitamins in the prevention of cardiovascular disease in men.

GAUSS trial: Antibodies for the treatment of hypercholesterolemia in patients with statin intolerance.

Últimas Noticias

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

Long Term Results of the International Chimney Registry

Noticias Institucionales

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Accesos